Research Article Details
| Article ID: | A44183 |
| PMID: | 29475442 |
| Source: | Lipids Health Dis |
| Title: | Correction to: A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease. |
| Abstract: | Following publication of the original article [1], the corresponding author reported that he had mistyped the first author's unit. The affiliation of Zhonge Chen, "Medical Center of the Graduate School, Nanchang University, China", should be changed to "Department of Gastroenterology, Second Affiliated Hospital, Nanchang University Nanchang, China". All the other authors have agreed to this change. The corrected version should be as follows. |
| DOI: | 10.1186/s12944-018-0678-8 |
| Strategy ID | Therapy Strategy | Synonyms | Therapy Targets | Therapy Drugs | |
|---|---|---|---|---|---|
| S01 | Improve insulin resistance | insulin sensitizer; insulin resistance; glucose tolerance | Biguanide: increases 5-AMP activated protein kinase signaling; SGLT-2 inhibitor; Thiazalidinedione: selective PPAR-γ agonists; GLP-1 agonist | Metformin; Empagliflozin; Canagliflozin; Rosiglitazone; Pioglitazone; Liraglutide | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Diseases ID | DO ID | Disease Name | Definition | Class | |
|---|---|---|---|---|---|
| I05 | 9352 | Type 2 diabetes mellitus | A diabetes that is characterized by chronic hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action, or both. A diabetes mellitus that is characterized by high blood sugar, insulin resistance, and relative lack of insulin. http://en.wikipedia.org/wiki/Diabetes, http://en.wikipedia.org/wiki/Diabetes_mellitus_type_2 | disease of metabolism/inherited metabolic disorder/ carbohydrate metabolic disorder/glucose metabolism disease/diabetes/ diabetes mellitus | Details |